Coronavirus
The case for teaching students outside this fall
Transitioning to outdoor classrooms this fall could help stem the spread of COVID-19 in schools and protect students, according to researchers.
Oxford COVID-19 vaccine triggers strong immune response
An Oxford COVID-19 vaccine triggered the creation of antibodies and T cells in trial participants, according to promising results published in The Lancet.
Doctors debate over using radiation therapy for COVID-19
Citing evidence from the past and recent, small trials, some doctors are calling for low-dose radiation therapy for COVID-19 patients. Controversy has followed.
New NFL mouth shield could protect players from COVID-19
The NFL’s mouth shield is designed to stop respiratory droplets. But player’s reactions have been mixed.
How to explain falling COVID-19 mortality rates
COVID-19 mortality rates are dropping in the U.S. and other nations — a few theories explain why more people are surviving the coronavirus.
"T cells" could provide immunity after antibodies fade
T cells that combat SARS-CoV-2 have been discovered in people who never had COVID-19, potentially putting natural herd immunity within our grasp.
Bats may provide clues for treating COVID-19
Bats have long lives despite playing host to numerous viruses. Three scientists believe bats' immune systems may help develop new ways of treating COVID-19.
Moderna’s COVID-19 vaccine produces more antibodies than infection
Two shots of Moderna’s COVID-19 vaccine produces more antibodies than a coronavirus infection, according to Phase 1 preliminary data.
Study: Risk of death from COVID-19 is 45% lower on arthritis drug
The arthritis drug tocilizumab may lower ventilated patients' risk of death from COVID-19 by 45%, according to a retrospective study.
Survivors’ plasma might prevent coronavirus infections
Injections of COVID-19 survivors' blood plasma might prevent coronavirus infections, making them a promising stopgap until a vaccine is ready.